Berual, Xyrene Nicole B.
HRN: 22-19-18 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/11/2022
MUPIROCIN 2%, 15G (TUBE)
11/11/2022
11/18/2022
TOPICAL
Apply Generously To Affected Site
BID
Soft Tissue Infection
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes